Profil
Chris Bunge is currently a Senior Analyst at Opaleye Management, Inc. since 2023.
Formerly, Mr. Bunge was a Portfolio Manager at WaterMill Asset Management from 2017 to 2024 and an Analyst at Manalapan Oracle Advisers LLC from 2013 to 2014.
Mr. Bunge completed an undergraduate degree at Bentley University in 2013.
Aktive Positionen von Chris Bunge
| Unternehmen | Position | Beginn |
|---|---|---|
Opaleye Management, Inc.
Opaleye Management, Inc. Investment ManagersFinance Opaleye employs a research process that involves analyzing company fundamentals, such as asset valuations, quality of management, likely catalysis and/ or innovative products and the competition. The firm’s strategy for managing the Fund is to actively invest, both long and short, in equity securities of US and foreign small and mid-cap biotechnology, specialty pharmaceutical and med-device companies. | Analyst-Equity | 01.11.2023 |
Ehemalige bekannte Positionen von Chris Bunge
| Unternehmen | Position | Ende |
|---|---|---|
WaterMill Asset Management
WaterMill Asset Management Investment ManagersFinance WaterMill Asset Management invests in both private and public companies. | Portfolio Manager-Aktien | 01.01.2024 |
Manalapan Oracle Advisers LLC
Manalapan Oracle Advisers LLC Investment ManagersFinance Profile Unavailable. | Analyst-Equity | 01.04.2014 |
Ausbildung von Chris Bunge
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Bentley University
Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opaleye Management, Inc.
Opaleye Management, Inc. Investment ManagersFinance Opaleye employs a research process that involves analyzing company fundamentals, such as asset valuations, quality of management, likely catalysis and/ or innovative products and the competition. The firm’s strategy for managing the Fund is to actively invest, both long and short, in equity securities of US and foreign small and mid-cap biotechnology, specialty pharmaceutical and med-device companies. | Finance |
Manalapan Oracle Advisers LLC
Manalapan Oracle Advisers LLC Investment ManagersFinance Profile Unavailable. | Finance |
WaterMill Asset Management
WaterMill Asset Management Investment ManagersFinance WaterMill Asset Management invests in both private and public companies. | Finance |
















